Skip to content

Physiological Umbilical Cord Clamping in Patients With Congenital Diaphragmatic Hernia. Clinical Trial

Physiological Umbilical Cord Clamping in Patients With Congenital Diaphragmatic Hernia. Clinical Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06408376
Enrollment
80
Registered
2024-05-10
Start date
2022-06-14
Completion date
2026-12-31
Last updated
2024-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Diaphragmatic Hernia, Delayed Umbilical Cord Separation, Umbilical Cord Clamping

Brief summary

Congenital diaphragmatic hernia (CDH) is a malformation that affects 1 in every 3000 newborns. The diaphragm does not complete its closure during embryogenesis, which allows the abdominal organs to herniate into the thoracic cavity altering lung development. The lungs of patients with CDH are small, with a decreased surface area for gas exchange and developmental impair of the pulmonary vasculature, resulting in respiratory failure and pulmonary hypertension shortly after birth. When clamping the umbilical cord, a large part of the preload is abruptly excluded, generating an increase in vascular resistance, which in turn increase the afterload, resulting in a decrease in cardiac output. The output is restored by decreasing vascular resistance in pulmonary circuit after lung aeration upon receiving the preload of the right atrium, increasing pulmonary flow and thus sustaining the preload of the left ventricle. If pulmonary aeration occurs before clamping the umbilical cord, the pulmonary blood flow increases before placenta flow is lost, thus avoiding a decrease in cardiac output. This modality has been called physiological base cord clamping (PFC). The hypothesis is that PFC once ventilation has been established could prevent hypoxia and improve cardiac output in newborns with CDH and secondarily improve their hemodynamic parameters, stabilizing gas exchange and pulmonary hypertension during the first 24 hours of birth.

Detailed description

* Type of study: Randomized clinical trial * Primary objective: To establish the effectiveness of PFC in reducing hypoxia and improving cardiac output compared to immediate postintubation clamping in newborns with CDH. To establish the safety and feasibility of PFC after pulmonary recruitment achieved post intubation. * Secondary objectives: describe the evolution of patients with CDH 24 hours after birth under pre-established conditions. Relate prenatal indices to the subsequent evolution of these patients. Describe maternal evolution and postpartum complications. * Population: Patients who attend the Fetal Diagnosis and Treatment program of Garrahan Children's Hospital and undergo prenatal diagnosis of CDH are possible candidates. The study will be carried out in the Neonatal Intensive Care Unit of said hospital. * Scope of the study: Garrahan Children's Hospital is a level 3 B pediatric hospital and national referral center located in Autonomous City of Buenos Aires, Argentina. Center that receives neonates with CDH referred from all over the country as well as from other countries in the region and carries out the relevant training for equal reception. * Block randomization: will be carried out on the same day, 2 hours before entering the delivery room * Intervention: Immediately after birth, the newborn will be placed on a mobile table, made to received these patients in the delivery room, at the level of the mother's womb, leaving the umbilical cord intact, intubated and gently ventilated (positive inspiration pressure (PIM) 15/25 - positive end expiratory pressure (PEEP)4 - fraction of inspired oxygen inspired oxygen fraction (FiO2) 50%), until saturation \>85% and heart rate (HR) \>100 or 10 timed minutes pass, whichever occurs first, the umbilical cord will be clamped and continued with the usual reception steps in accordance with the unit´s CDH reception protocol. * Sample size: To calculate the sample size, a prevalence of hemodynamic alterations of 60% was considered in the first 24 hours of life of patients with CDH, following unit statistics and the aforementioned bibliography. The estimated sample size with a relative reduction of 50%: reduction from 60% to 30% of hemodynamic alterations - Power of 80% - Two-tailed test - alpha 5%. 40 patients required in each branch.

Interventions

PROCEDUREPhysiological cord clamping

Immediately after birth, the newborn with prenatal diagnosis of CDH will be placed on a mobile table, made to receive these patients in the delivery room, at the level of the mother's womb, leaving the umbilical cord intact and intubated. The patient will be gently ventilated (PIM 15/25 - PEEP 4 - Fio2 50%), until saturation \>85% and HR\>100 or 10 timed minutes have elapsed, whichever occurs first, the umbilical cord will be clamped.

Sponsors

Hospital JP Garrahan
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Prenatal diagnosis of congenital diaphragmatic hernia * gestational age \>34 weeks * Informed consent signed by the patient's parents

Exclusion criteria

* Multiple gestation * Major malformation or fetal genetic anomaly diagnosed in the prenatal stage * Emergency cesarean section or maternal condition that prevents the approach * Lack of informed consent

Design outcomes

Primary

MeasureTime frameDescription
Hemodynamic deterioration in the first 24 hours of life24 hours of lifeHemodynamic deterioration in the first 24 hours of life (meeting 3 of 4 of the following criteria or entry to extracorporeal membrane oxygenation (ECMO) or Death). 1. Pre/post ductal saturation difference \>10% 2. Oxygenation index (IO) \>20 3. mean arterial pressure \< Percentile 50 or inotrope requirement 4. Lactic acid \>3 mmol/l
complete delivery according groupdeliveryComplete the protocol in the delivery room pre-established according to randomization (yes/no)

Secondary

MeasureTime frameDescription
near-infrared spectroscopy (Nirs) on the first day2 - 4 hours and 24 hours of lifeCerebral and somatic NIRS
lung volumenfrom 26 to 32 weeks of gestational agelung volumen in RMI
Intubation timeFrom delivery to intubationTime to intubation (minutes, seconds)
Cord clamping timefrom delivery to cord clampingCord clamping time (minutes, seconds)
Advance resuscitation need on delivery roomfrom delivery to 30 minutes of lifeRequirement for advanced resuscitation (yes/no) (compressions, drugs, hypothermia)
Time to reach heart rate (HR) >100from delivery to 30 minutes of lifeTime to reach HR \>100 (minutes, seconds)
Time to reach saturation (SAT) >85%from delivery to 30 minutes of lifeTime to reach SAT \>85% (minutes, seconds)
Cord PH valueinmediatly after cord clamppingcord ph value
Cord lactic acid valueinmediatly after cord clamppingcord lactic acid value in mmol/l
saturation at 10 minutes10 minutes of lifepre and post ductal saturation %
Arterial pressure at 10 minutes10 minutes of lifemean arterial tension in mmhg
placenta abruption30 minutes of lifeTime for placental abruption (minutes, seconds)
Mother arterial tension after delivery10 minutes after deliverymothers arterial mean tension after delivery in mmhg
Uterotonic use30 minutes after deliveryuterotonics use on mothers after delivery (yes/no)
Evolution of patient Blood preassure (BP)2 - 4 hours and 24 hours of lifeBlood pressure in mmhg
Evolution of patient inotropes required2 - 4 hours and 24 hours of lifeInotrope requirement (yes/no)
Inhaled nitric oxide (NOi) requirement2 - 4 hours and 24 hours of lifeNOi requirement (yes/no)
ventilation requirements on the first day2 - 4 hours and 24 hours of lifeVentilatory mode / mean airway pressure (MAP)/ FIo2 %
Oxygenation on the first day2 - 4 hours and 24 hours of lifePartial arterial pressure of oxygen (PaO2) mmhg
Oxygenation index (OI) on the first day2 - 4 hours and 24 hours of lifeOI
B natriuretic peptide (BNP) on the first day24 hours of lifeB natriuretic peptide (BNP)
PH value on the first day6 and 24 hours of lifeechocardiographic pulmonary hypertension PH (\<50% of systemic pressure, between 50-80% of systemic pressure, between 80 and 100% of systemic pressure, systemic, suprasystemic)
cardiac malformations6 hours of lifecardiac malformation (yes/no)
Mortalitythrough study completion, an average of 1 yearMortality (yes/no)
Admission to ECMOthrough study completion, an average of 1 yearAdmission to ECMO after the first 24 hours (yes/no)
Mcgoonfrom 26 to 32 weeks of gestational ageMcgoon Index in fetal echocardiogram
maternal hematocrit1 day before deliverymaternal hematocrit in gr/dl
Gestational age at diagnosis1st day of lifeGestational age at diagnosis of CDH in weeks
Lung heart rate index observed/expected LHR O/Efrom 26 to 32 weeks of gestational agelung heart rate index observed/expected (LHR O/E)
liver in thoraxfrom 26 to 32 weeks of gestational ageliver in thorax (yes/no) and %
stomach herniationfrom 26 to 32 weeks of gestational agestomach herniation (yes/no) and %

Other

MeasureTime frameDescription
Patent ductus arteriosus (PAD) on the first day (size)6 and 24 hours of lifePatent ductus arteriosus (PAD): size in milimeters
Patent ductus arteriosus (PAD) on the first day (gradient)6 and 24 hours of lifePatent ductus arteriosus (PAD): gradient
Patent ductus arteriosus (PAD) on the first day (shunt direction)6 and 24 hours of lifePatent ductus arteriosus (PAD): shunt direction
Patent foramen ovale (PFO) on the first day (shunt direction)6 and 24 hours of lifePatent foramen ovale (PFO): shunt direction.
Right ventricle (RV) on the first day diameter6 and 24 hours of lifeRight ventricle (RV): RV diameter in milimeters
Right ventricle (RV) on the first day TAPSE6 and 24 hours of lifeRight ventricle (RV): TAPSE
Tricuspide Insufitienty6 and 24 hours of lifetricuspide insufitienty
Right ventricle funtion6 and 24 hours of lifeRight ventricle global disfuntion : no, mild, moderate or severe
Left ventricle (LV) on the first day (eccentricity index)6 and 24 hours of lifeLeft ventricle (LV): eccentricity index
Left ventricle (LV) on the first day (ejection fraction)6 and 24 hours of lifeLeft ventricle (LV): ejection fraction (EF)
Left ventricle (LV) on the first day global funtion6 and 24 hours of lifeLeft ventricle (LV) global disfuntion : no, global disfuntion : no, mild, moderate or severe
Interventricular septum (IS) on the first day6 and 24 hours of lifeInterventricular septum: configuration
Pulmonary hypertation grade on the first day6 and 24 hours of lifePulmonary hypertation: no, mild, moderate or severe
Associated malformations24 hours of lifeAssociated malformations (yes/no), which
Chromosomopathy or genetic alterationthrough study completion, an average of 1 yearChromosomopathy or genetic alteration (yes/no), which
HyperbilirubinemiaFrom date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 monthsHyperbilirubinemia requiring phototherapy or exchange transfusion (yes/no)
Early sepsisFrom date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 monthsEarly sepsis (yes/no)
OmphalitisFrom date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 monthsOmphalitis (yes/no)
CDH surgeryFrom date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 monthsCDH surgery (yes/no), days of life
Surgical classificationFrom date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 monthsSurgical classification of CDH (a-b-c-d)
Days in neonatal intensive care unit (NICU)From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 monthsDays in NICU
baby weight30 minutes of lifeWeight in grams
maternal agethrough study completion, an average of 1 yearmaternal age during pregnancy
maternal historythrough study completion, an average of 1 yearmaternal pathological history during pregnancy (yes/no)

Countries

Argentina

Contacts

Primary ContactMariela Jozefkowicz
mjozefkowicz@garrahan.gov.ar+5491164646270
Backup ContactMaria T Mazzucchelli
mtmazzu@gmail.com+5491149170437

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026